Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors

  • Salvia, Roser|||0000-0002-2118-9231
  • G. Rico, Laura|||0000-0001-9867-4393
  • Morán, Teresa
  • Bradford, Jolene A.
  • Ward, Michael D.
  • Drozdowskyj, Ana
  • Climent Martí, Joan|||0000-0002-3366-2241
  • Martínez-Cáceres, Eva M.
  • Rosell, Rafael|||0000-0003-0817-3400
  • Petriz, Jordi|||0000-0003-1085-0511
Even though anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC) have improved survival, a high percentage of patients still do not respond to ICIs. Myeloid-derived suppressor cells (MDSCs) are circulating cells that express PD-L1 and can infiltrate and proliferate in the tumor microenvironment, inducing immunosuppression. By evaluating changes in PD-L1 expression of live peripheral blood MDSCs, we are able to define a new PD-L1 index, useful in predicting ICI escape in NSCLC patients before initiating anti-PD-1/PD-L1 immunotherapy. In this study, a cohort of 37 NSCLC patients was prospectively analyzed, obtaining independent PD-L1 indexes. In patients with a PD-L1 index.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prospective Investigation of Nanoplastic Accumulation in Healthy Subjects, Autoimmune Diseases, Hematological Malignancies, Lung Cancer, and Murine Models

  • Salvia, Roser|||0000-0002-2118-9231
  • Cañaveras, Manel
  • G. Rico, Laura|||0000-0001-9867-4393
  • Drozdowskyj, Ana
  • Ward, Michael D.
  • Jurado, Rebeca
  • Gómez Muñoz, Laia|||0000-0001-9640-6213
  • Vives-Pi, Marta
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
  • Petriz, Jordi|||0000-0003-1085-0511
Nanoplastics (NPs) and microplastics (MPs) are an emerging threat to global health. They negatively impact ecosystems and many physiological processes, causing alterations in xenobiotic metabolism, nutrient uptake, energy metabolism, or cytotoxicity. In humans, we are beginning to analyze these plastics for the mechanisms by which they enter the organism, accumulate, and diffuse as well as for their pathogenic potential. NP accumulation has been demonstrated in human tissues, such as blood or placenta, while in others it remains largely unstudied. In this work, we detected NP accumulation in bronchoalveolar lavage fluids (BALFs), cerebrospinal fluids (CSFs), lymph nodes (LNs), urine, pleural fluids (PFs), ascitic fluids (AFs), and peripheral blood (PB) by combining fluorescence and nanocytometry techniques. NP analysis was compared with two strains of mice, and the results support that inhalation is the main route of NP accumulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evaluation of blood cytotoxicity against tumor cells using a live-cell imaging platform

  • Salvia, Roser|||0000-0002-2118-9231
  • G. Rico, Laura|||0000-0001-9867-4393
  • Morán, Teresa
  • Olszowy, Michael W.
  • Ward, Michael D.
  • Petriz, Jordi|||0000-0003-1085-0511
Cellular cytotoxicity is an important mechanism of the immune system to clear infections and eliminate tumor cells. Its two main mediators are cytotoxic T lymphocytes and natural killer (NK) cells. In lung cancer, intratumoral NK cells show reduced cytolytic potential and one third of patients do not express HLA-I proteins, which activate NK cells in a process termed "absent self-recognition". In this work, we investigate NK cytotoxicity as a potential oncological biomarker that informs patient status and predicts response to treatment. We describe a simple and rapid test to analyze NK cytotoxicity without the need for large volumes of blood, requiring short processing time and reduced use of both reagents and blood samples, using the IncuCyte live imaging technique.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients

  • López, Cristina
  • Depreux Niño, Nathalie|||0000-0003-2186-2059
  • Bielsa, Isabel
  • Roger, Albert
  • Quirant, Bibiana|||0000-0002-3875-8074
  • Basagaña Torrentó, Maria|||0000-0002-5478-5945
  • Jurgens, Yanina
  • Padró-Casas, Clara|||0000-0003-0139-5836
  • Miquel, Sira
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
  • Teniente Serra, Aina|||0000-0003-3440-804X
Background: Chronic spontaneous urticaria (CSU) is a highly prevalent and difficult to manage cutaneous disease characterized by the presence of recurrent urticaria, angioedema, or both, for a period of 6 weeks or longer. One of the biological treatments used for patients with CSU with an autoimmune background and bad control of the disease is omalizumab, an anti-IgE monoclonal antibody. The understanding of the mechanism of action of this biological drug in CSU along with the identification of potential biomarkers of clinical response can be helpful in the personalized management of the disease. Objective: The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response. Methods: We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. An exhaustive immunophenotyping of whole blood T-cell subpopulations, including naïve, central memory, effector memory, effector cells, Th1, Th2, and Th17 was performed by multiparametric flow cytometry. Moreover, in CSU patients, we analyzed markers of inflammation (ESR, DD, CRP), atopy (prick test, IgE quantification), and autoimmunity (anti-thyroid antibodies and indirect basophil activation test).To evaluate the clinical activity, the Urticaria Activity Score 7 (UAS 7) test was used. Results: In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. Moreover, patients under treatment with omalizumab had higher percentages of Th1 and Th2 cells than patients under treatment with NID. Conclusion: The immune monitoring of T-cell subpopulations in patients with CSU starting omalizumab, may be a useful strategy to analyze treatment response in the clinical practice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Efficacy of cognitive rehabilitation in cognition and brain networks, A randomised clinical trial in patients with multiple sclerosis

  • Lopez-Soley, Elisabet
  • Martinez-Heras, Eloy|||0000-0001-9937-3162
  • Vivó Pascual, Francesc|||0000-0002-6409-1197
  • Calvi, Alberto|||0000-0002-1953-2803
  • Alba-Arbalat, Salut|||0000-0003-1662-2317
  • Romero Pinel, Lucía|||0000-0001-8054-0565
  • Martínez Yélamos, Sergio|||0000-0001-9889-2040
  • Ramo-Tello, Cristina|||0000-0001-8643-5053
  • Presas Rodríguez, Sílvia|||0000-0001-8545-2476
  • Munteis, Elvira|||0000-0002-6195-9106
  • Martínez-Rodríguez, José Enrique
  • Sastre-Garriga, Jaume|||0000-0002-1589-2254
  • Anglada, E.|||0000-0001-5074-4970
  • Meza-Murillo, Edwin Roger|||0000-0001-6065-3546
  • Arévalo, María Jesús|||0000-0003-0626-5555
  • Sánchez Carrión, Rocío
  • Pelayo, Raúl|||0000-0002-1313-0686
  • Bernabeu Guitart, Montserrat|||0000-0003-2037-3069
  • Sola-Valls, Nuria
  • Hervas, M.
  • Sepúlveda, María
  • Saiz, Albert|||0000-0002-5793-8791
  • Blanco Morgado, Yolanda|||0000-0002-1834-0498
  • Solana, Elisabeth|||0000-0001-7973-2439
  • Llufriu, Sara|||0000-0003-4273-9121
This study evaluated the efficacy of the computerised Guttmann, NeuroPersonalTrainer® (GNPT) cognitive rehabilitation (CR) and characterised the induced changes in cerebral networks in patients with multiple sclerosis (MS). This multicentre, double-blind, randomised clinical trial compared upward intensity training (active treatment) to low-intensity static training (static treatment). Cognition was assessed using the Brief Repeatable battery before and after 12 weeks of training and at 10-months follow-up, and patients were classified as having a mild or severe cognitive impairment (CI). Brain MRI pre- and post-CR were analysed using an advanced tractography algorithm, based on multishell diffusion MRI, to obtain node-based graph metrics (local efficiency and strength) from microscopic fractional anisotropy. Seventy MS patients completed the study (age 48.9 ± 8.8, disease duration 16.8 ± 9.0 years); active treatment: 36, static treatment: 34. Verbal memory improved significantly post-CR in both groups (55 % active; 34 % static treatment), accompanied by increases in local efficiency and strength in multimodal regions. At follow-up, verbal memory declined in both groups but remained above the pre-CR assessment (-25 % and -17 %, respectively). Patients with severe-CI (n = 36) showed improvement only with active treatment, while those with mild-CI (n = 34) improved regardless of intensity treatment. Network changes were more pronounced in patients in active treatment and in those with severe-CI. Quality of life did not change at post-CR, and cognitive improvement was influenced by cognitive reserve (p = 0.011). In MS, GNPT temporarily improves verbal memory and increases network connectivity, reinforcing the CR as a valuable tool for enhancing cognitive skills and promoting neuronal plasticity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reprogramming autoimmunity, inducing antigen-specific tolerance via apoptotic mimicry in an experimental model of multiple sclerosis

  • Eixarch, Herena|||0000-0001-7525-9533
  • Boutitah-Benyaich, Imane
  • Plaza, Jorge
  • Rodríguez-Vidal, Sílvia
  • Salvadó, Míriam
  • Mancera-Arteu, Montserrat
  • Almenara-Fuentes, Lidia|||0000-0002-8518-8078
  • Dalmases, Martí
  • Vives Pi, Marta|||0000-0003-3735-0779
  • Montalban, Xavier|||0000-0002-0098-9918
  • Barneda Zahonero, Bruna|||0000-0002-6557-5222
  • Espejo, Carmen|||0000-0001-9949-5901
Multiple sclerosis (MS) is an immune-mediated disorder characterized by demyelination, axonal damage, and neurodegeneration, leading to neurological disability in patients. It is considered a prototypic antigen-specific autoimmune disease, and therefore is a strong candidate for therapies aimed at restoring immune tolerance to self-antigens. However, the development of effective antigen-specific tolerization remains an important unmet medical need. In the present study, we administered phosphatidylserine (PS) liposomes, mimicking apoptotic bodies, containing a myelin antigen [35-55 myelin oligodendrocyte glycoprotein (MOG) peptide] in the MOG-induced experimental autoimmune encephalomyelitis (EAE), as a therapeutic strategy for the treatment of MS. MOG PS liposomes or empty PS liposomes were administered in a single administration before or after the appearance of EAE neurological symptoms. Intraperitoneal, intranasal, intradermal and intravenous administration routes were used. For mechanistic studies, peripheral T and B cell subpopulations of treated EAE mice were studied by flow cytometry. In addition, EAE mice treated with MOG PS liposomes received blocking antibodies to deplete Treg, B cells, and immunomodulatory mediators IL-10 and TGF-β. The efficacy of the therapy was compared with daily administration of fingolimod. We demonstrated the therapeutic efficacy of the MOG-loaded PS liposomes when administered intraperitoneally before onset, and the mechanism of action of MOG-loaded PS liposomes involved Treg and B cells, since blocking these populations and their related molecules IL-10 and TGF-β, abrogated the tolerogenic effect of the therapy. We also demonstrated the therapeutic efficacy of the MOG-loaded PS liposomes when administered intraperitoneally after appearance of EAE neurological signs. Alternative routes of administration such as intravenous and intradermal, which are more suited for translation in clinical trials, were found to be efficacious before and after appearance of EAE neurological signs. Intravenous administration of MOG-loaded PS liposomes in established EAE reduced dendritic cell activation, decreased inflammatory cytokine secretion, induced T cell exhaustion and expanded regulatory B cells (Breg) and CD39 + CD4 + FoxP3 + T cells. Our findings indicate that antigen-specific therapy with PS liposomes mimicking apoptotic bodies downregulates the MOG-specific inflammatory immune response and expands Breg and Treg cells, offering a safe, versatile, and easily applicable approach that strongly supports its potential for near-future clinical translation in MS. The online version contains supplementary material available at 10.1186/s12974-025-03618-w.